Literature DB >> 26451082

The National Diabetes Prevention Program: From Research to Reality.

Ann Albright1.   

Abstract

The significant rise and projected trends in the incidence of type 2 diabetes argue for a concerted effort on prevention. The strongest currently available evidence for diabetes prevention involves people at high risk for type 2 diabetes (i.e., those with prediabetes). Randomized, controlled trials and translation studies have demonstrated that type 2 diabetes can be prevented or delayed through a structured lifestyle intervention that can be delivered cost-effectively in a variety of settings. For the first time in the United States, a coordinated, focused effort is underway to bring this effective and cost-conscious lifestyle intervention to communities across the country to ultimately reduce the incidence of type 2 diabetes.

Entities:  

Year:  2012        PMID: 26451082      PMCID: PMC4593752     

Source DB:  PubMed          Journal:  Diabetes Care Educ Newsl        ISSN: 1070-5945


  5 in total

Review 1.  How effective were lifestyle interventions in real-world settings that were modeled on the Diabetes Prevention Program?

Authors:  Mohammed K Ali; Justin Echouffo-Tcheugui; David F Williamson
Journal:  Health Aff (Millwood)       Date:  2012-01       Impact factor: 6.301

2.  Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.

Authors:  William C Knowler; Elizabeth Barrett-Connor; Sarah E Fowler; Richard F Hamman; John M Lachin; Elizabeth A Walker; David M Nathan
Journal:  N Engl J Med       Date:  2002-02-07       Impact factor: 91.245

3.  Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence.

Authors:  James P Boyle; Theodore J Thompson; Edward W Gregg; Lawrence E Barker; David F Williamson
Journal:  Popul Health Metr       Date:  2010-10-22

4.  10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study.

Authors:  William C Knowler; Sarah E Fowler; Richard F Hamman; Costas A Christophi; Heather J Hoffman; Anne T Brenneman; Janet O Brown-Friday; Ronald Goldberg; Elizabeth Venditti; David M Nathan
Journal:  Lancet       Date:  2009-10-29       Impact factor: 79.321

Review 5.  Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: a systematic overview and meta-analysis of prospective studies.

Authors:  Hertzel C Gerstein; Pasqualina Santaguida; Parminder Raina; Katherine M Morrison; Cynthia Balion; Dereck Hunt; Hossein Yazdi; Lynda Booker
Journal:  Diabetes Res Clin Pract       Date:  2007-06-29       Impact factor: 5.602

  5 in total
  13 in total

1.  Is the use of metformin in patients undergoing dialysis hazardous for life? A systematic review of the safety of metformin in patients undergoing dialysis.

Authors:  Christina Abdel Shaheed; Jane E Carland; Garry G Graham; Sophie L Stocker; Greg Smith; Mark Hicks; Kenneth M Williams; Timothy Furlong; Peter Macdonald; Jerry R Greenfield; Felicity C Smith; Gina Chowdhury; Richard O Day
Journal:  Br J Clin Pharmacol       Date:  2019-12-09       Impact factor: 4.335

2.  Primary Care Cluster RCT to Increase Diabetes Prevention Program Referrals.

Authors:  James W Keck; Karen L Roper; Laura B Hieronymus; Alisha R Thomas; Zhengyuan Huang; Philip M Westgate; John L Fowlkes; Roberto Cardarelli
Journal:  Am J Prev Med       Date:  2020-05-14       Impact factor: 5.043

3.  Better Me Within Randomized Trial: Faith-Based Diabetes Prevention Program for Weight Loss in African American Women.

Authors:  Heather Kitzman; Abdullah Mamun; Leilani Dodgen; Donna Slater; George King; Alene King; J Lee Slater; Mark DeHaven
Journal:  Am J Health Promot       Date:  2020-09-18

4.  Changes in Disparity in County-Level Diagnosed Diabetes Prevalence and Incidence in the United States, between 2004 and 2012.

Authors:  Sundar S Shrestha; Theodore J Thompson; Karen A Kirtland; Edward W Gregg; Gloria L Beckles; Elizabeth T Luman; Lawrence E Barker; Linda S Geiss
Journal:  PLoS One       Date:  2016-08-03       Impact factor: 3.240

5.  NHS Diabetes Prevention Programme in England: formative evaluation of the programme in early phase implementation.

Authors:  Linda Penn; Angela Rodrigues; Anna Haste; Marta M Marques; Kirsten Budig; Kirby Sainsbury; Ruth Bell; Vera Araújo-Soares; Martin White; Carolyn Summerbell; Elizabeth Goyder; Alan Brennan; Ashley J Adamson; Falko F Sniehotta
Journal:  BMJ Open       Date:  2018-02-21       Impact factor: 2.692

6.  Diabetes mortality rates among African Americans: A descriptive analysis pre and post Medicaid expansion.

Authors:  Christopher J King; Jonathan Moreno; Susan V Coleman; John F Williams
Journal:  Prev Med Rep       Date:  2018-08-04

7.  Effect of dose of behavioral weight loss treatment on glycemic control in adults with prediabetes.

Authors:  Viviana Bauman; Aviva H Ariel-Donges; Eliza L Gordon; Michael J Daniels; Dandan Xu; Kathryn M Ross; Marian C Limacher; Michael G Perri
Journal:  BMJ Open Diabetes Res Care       Date:  2019-05-28

8.  Implementing Lifestyle Change Interventions to Prevent Type 2 Diabetes in US Medicaid Programs: Cost Effectiveness, and Cost, Health, and Health Equity Impact.

Authors:  Michael Laxy; Ping Zhang; Boon Peng Ng; Hui Shao; Mohammed K Ali; Ann Albright; Edward W Gregg
Journal:  Appl Health Econ Health Policy       Date:  2020-10       Impact factor: 2.561

9.  Levoketoconazole in the Treatment of Patients With Cushing's Syndrome and Diabetes Mellitus: Results From the SONICS Phase 3 Study.

Authors:  Rosario Pivonello; Atanaska Elenkova; Maria Fleseriu; Richard A Feelders; Przemyslaw Witek; Yona Greenman; Eliza B Geer; Paola Perotti; Leonard Saiegh; Fredric Cohen; Giorgio Arnaldi
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-07       Impact factor: 5.555

10.  Toward targeted prevention: risk factors for prediabetes defined by impaired fasting glucose, impaired glucose tolerance and increased HbA1c in the population-based KORA study from Germany.

Authors:  Gregory G Greiner; Karl M F Emmert-Fees; Jana Becker; Wolfgang Rathmann; Barbara Thorand; Annette Peters; Anne S Quante; Lars Schwettmann; Michael Laxy
Journal:  Acta Diabetol       Date:  2020-08-03       Impact factor: 4.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.